Fmoc-O-(benzylphospho)-L-serine structure
|
Common Name | Fmoc-O-(benzylphospho)-L-serine | ||
---|---|---|---|---|
CAS Number | 158171-14-3 | Molecular Weight | 497.434 | |
Density | 1.4±0.1 g/cm3 | Boiling Point | N/A | |
Molecular Formula | C25H24NO8P | Melting Point | N/A | |
MSDS | Chinese USA | Flash Point | N/A |
Use of Fmoc-O-(benzylphospho)-L-serineFmoc-Ser(HPO3Bzl)-OH is a serine derivative[1]. |
Name | Fmoc-O-benzyl-L-phosphoserine |
---|---|
Synonym | More Synonyms |
Description | Fmoc-Ser(HPO3Bzl)-OH is a serine derivative[1]. |
---|---|
Related Catalog | |
In Vitro | Amino acids and amino acid derivatives have been commercially used as ergogenic supplements. They influence the secretion of anabolic hormones, supply of fuel during exercise, mental performance during stress related tasks and prevent exercise induced muscle damage. They are recognized to be beneficial as ergogenic dietary substances[1]. |
References |
Density | 1.4±0.1 g/cm3 |
---|---|
Molecular Formula | C25H24NO8P |
Molecular Weight | 497.434 |
Exact Mass | 497.123962 |
PSA | 141.20000 |
LogP | 4.74 |
Index of Refraction | 1.623 |
Storage condition | 2-8°C |
Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
---|---|
Hazard Codes | Xi |
RIDADR | NONH for all modes of transport |
WGK Germany | 3 |
J.W. Perich et al.
Lett. Pept. Sci. 6 , 91, (1999)
|
|
P. White, J. Beythien
Innovation Perspect. Solid Phase Synt. Comb. Libr., 4th Int. Symp. , 557, (1995)
|
|
H. Schmid et al.
Innovation Perspect. Solid Phase Synt. Comb. Libr., 4th Int. Symp. , 525, (1995)
|
(2S)-3-{[(Benzyloxy)(hydroxy)phosphoryl]oxy}-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}propanoic acid |
Fmoc-Ser(PO3BzlH)-OH |
MFCD00797869 |
L-Serine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-O-[hydroxy(phenylmethoxy)phosphinyl]- |
N-Fmoc-O-(Benzyl Phosphoryl)-L-Serine |
Fmoc-O-(benzylphospho)-L-serine |
Fmoc-Ser(HPO3Bzl)-OH |
O-[(Benzyloxy)(hydroxy)phosphoryl]-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-serine |